[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.179.146. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,802
Citations 0
Letters
January 2, 2013

Omega-3 Fatty Acid Supplementation and Cardiovascular Disease Events

Author Affiliations
 

Letters Section Editor: Jody W. Zylke, MD, Senior Editor.

Author Affiliations: Department of Pharmacological and Biomolecular Sciences, Università di Milano, Milan, Italy (Dr Galli); and Division of Nutritional Sciences, Cornell University, Ithaca, New York (Dr Brenna; jtb4@cornell.edu).

JAMA. 2013;309(1):27. doi:10.1001/jama.2012.116648

To the Editor: The meta-analysis on omega-3 PUFAs and major cardiovascular disease end points concluded that supplementation was not associated with lower risk of cardiovascular disease events.1 Such a conclusion, based on a summary statistical analysis of highly variable treatments, conflates specific drug therapies with the nutrients that supplements are intended to deliver.

First Page Preview View Large
First page PDF preview
First page PDF preview
×